Ambalal Sarabhai Enterprises Profit & Loss Annual

BSE: 500009 | NSE: - | ISIN: INE432A01017 | Sector: Major Drugs

56.70 +1.57 (2.85%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	173.57	170.28	196.75	163.64
Total Revenue	173.57	170.28	196.75	163.64
Costof Revenue Total	101.02	103.81	115.62	100.60
Gross Profit	72.55	66.47	81.12	63.04
Selling/ General/ Admin Expenses Total	27.70	56.02	54.33	62.80
Depreciation/ Amortization	3.57	2.76	2.32	2.41
Other Operating Expenses Total	38.54	-1.20	-1.13	-0.87
Total Operating Expense	170.83	161.49	186.34	165.09
Operating Income	2.74	8.79	10.41	-1.45
Interest Inc( Exp) Net- Non- Op Total	-64.68	-0.97	69.22	87.92
Other Net	10.37	6.06	7.37	5.63
Net Income Before Taxes	6.65	14.83	54.19	32.54
Provisionfor Income Taxes	0.97	3.72	6.98	3.19
Net Income After Taxes	5.68	11.10	47.22	29.35
Minority Interest	0.00	0.00	0.00	0.00
Net Income Before Extra Items	5.68	11.10	47.22	29.36
Net Income	5.68	11.10	47.22	29.36
Income Availableto Com Excl Extra Ord	5.68	11.10	47.22	29.36
Income Availableto Com Incl Extra Ord	5.68	11.10	47.22	29.36
Diluted Net Income	5.68	11.10	47.22	29.36
Diluted Weighted Average Shares	7.68	7.66	7.66	7.66
Diluted EPS Excluding Extra Ord Items	0.74	1.45	6.16	3.83
Diluted Normalized EPS	0.74	1.44	4.53	1.53
Research Development	-	1.06	0.76	1.50
Unusual Expense( Income)	-	0.00	15.12	-
Gain( Loss)on Saleof Assets	-	0.67	294.94	195.61
Total Adjustmentsto Net Income	-	-0.01	-	-